These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11942046)

  • 1. Prevention of liver cancer: current strategies and future perspectives.
    Moriwaki H
    Int J Clin Oncol; 2002 Feb; 7(1):27-31. PubMed ID: 11942046
    [No Abstract]   [Full Text] [Related]  

  • 2. Can a vitamin prevent hepatocellular carcinoma?
    Venook AP
    Hepatology; 1997 Jan; 25(1):249-50. PubMed ID: 8985300
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemoprevention of primary liver cancer.
    Buiatti E
    IARC Sci Publ; 1996; (136):41-3. PubMed ID: 8791114
    [No Abstract]   [Full Text] [Related]  

  • 4. Current strategies for chemoprevention of hepatocellular carcinoma.
    Okita K; Sakaida I; Hino K
    Oncology; 2002; 62 Suppl 1():24-8. PubMed ID: 11868781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of FGF signaling: a putative mechanism for the chemopreventive effects of acyclic retinoid in hepatocellular carcinoma.
    Wang L; Levin MS
    Gastroenterology; 2005 Jan; 128(1):228-31. PubMed ID: 15633140
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
    Koga H
    Cancer; 2003 Aug; 98(4):661-7. PubMed ID: 12910508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic retinoids for the secondary prevention of hepatocellular carcinoma.
    Shafritz DA
    N Engl J Med; 1996 Jun; 334(24):1600-1. PubMed ID: 8628344
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemoprevention of hepatocellular carcinoma by acyclic retinoid].
    Nagaki M; Shimizu M; Moriwaki H
    Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):802-7. PubMed ID: 18525185
    [No Abstract]   [Full Text] [Related]  

  • 9. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma.
    Bishayee A; Politis T; Darvesh AS
    Cancer Treat Rev; 2010 Feb; 36(1):43-53. PubMed ID: 19910122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytochemicals in hepatocellular cancer prevention.
    Nishino H
    Nutr Cancer; 2009; 61(6):789-91. PubMed ID: 20155617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aspirin a day: the allure (and distraction) of chemoprevention.
    Levy IG; Pim CP
    J Natl Cancer Inst; 2012 Dec; 104(23):1782-4. PubMed ID: 23197493
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma.
    Seren S; Mutchnick M; Hutchinson D; Harmanci O; Bayraktar Y; Mutchnick S; Sahin K; Kucuk O
    Nutr Cancer; 2008; 60(6):729-35. PubMed ID: 19005972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamin K2 on the development of hepatocellular carcinoma in type C cirrhosis.
    Kojima K; Tamano M; Akima T; Hashimoto T; Kuniyoshi T; Maeda C; Majima Y; Kusano K; Murohisa T; Iijima M; Hiraishi H
    Hepatogastroenterology; 2010; 57(102-103):1264-7. PubMed ID: 21410069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of hepatocellular carcinoma by acyclic retinoid.
    Shimizu M; Sakai H; Moriwaki H
    Front Biosci (Landmark Ed); 2011 Jan; 16(2):759-69. PubMed ID: 21196201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of liver cancer by plant polyphenols.
    Stagos D; Amoutzias GD; Matakos A; Spyrou A; Tsatsakis AM; Kouretas D
    Food Chem Toxicol; 2012 Jun; 50(6):2155-70. PubMed ID: 22521445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence.
    Siegel AB; El-Serag HB
    Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):493-5. PubMed ID: 23984995
    [No Abstract]   [Full Text] [Related]  

  • 17. [Towards a chemoprevention of hepatocellular carcinoma?].
    Ganne-Carrié N; Christidis C; Beaugrand M
    Gastroenterol Clin Biol; 1997; 21(6-7):447-9. PubMed ID: 9295970
    [No Abstract]   [Full Text] [Related]  

  • 18. Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma.
    Okuno M; Sano T; Matsushima-Nishiwaki R; Adachi S; Akita K; Okano Y; Kojima S; Moriwaki H
    Jpn J Clin Oncol; 2001 Aug; 31(8):359-62. PubMed ID: 11574627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver.
    Borbath I; Leclercq I; Moulin P; Sempoux C; Horsmans Y
    Eur J Cancer; 2007 Jul; 43(11):1755-63. PubMed ID: 17582756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where are we in the chemoprevention of hepatocellular carcinoma?
    Lu SC
    Hepatology; 2010 Mar; 51(3):734-6. PubMed ID: 20198627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.